XML 93 R9.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Cash flows from operating activities:      
Net earnings $ 79,671 $ 78,573 $ 90,071
Adjustments to reconcile net earnings to net cash provided by operating activities:      
Depreciation and amortization 45,862 44,666 44,379
Stock compensation expense 7,596 6,413 6,264
Deferred income taxes (3,563) (5,403) (28,777)
Provision for doubtful accounts 1,776 43 69
Foreign currency transaction (gain)/loss 72 (141) 340
Asset impairment charge 1,140 1,801 0
(Gain)/Loss on disposal of assets (3,134) (3,244) 254
Changes in assets and liabilities, net of acquired balances      
Accounts receivable 11,623 (7,773) (3,906)
Inventories (11,401) (6,016) (319)
Prepaid expenses and other current assets 477 1,517 (439)
Accounts payable and accrued expenses 1,134 5,988 1,511
Income taxes (5,664) 1,121 449
Other (1,128) 1,152 722
Net cash provided by operating activities 124,461 118,697 110,618
Cash flows from investing activities:      
Capital expenditures and intangible assets acquired (28,413) (19,723) (28,117)
Cash paid for acquisitions, net of cash acquired (141,062) (17,399) (17,393)
Proceeds from sale of business and assets 11,523 966 22
Proceeds from insurance 2,727 4,165 2,792
Purchase of convertible note (1,000) 0 0
Net cash used in investing activities (156,225) (31,991) (42,696)
Cash flows from financing activities:      
Proceeds from revolving loan 168,569 210,750 25,000
Principal payments on revolving loan (76,000) (54,750) (44,000)
Principal payments on long-term debt 0 (219,500) (43,000)
Principal payment on acquired debt (17,567) (19) (2,384)
Cash paid for financing costs 0 (1,374) 0
Proceeds from stock options exercised 4,839 8,272 9,732
Dividends paid (15,135) (13,432) (12,069)
Purchase of treasury stock (21,321) (1,394) (1,905)
Net cash used in by financing activities 43,385 (71,447) (68,626)
Effect of exchange rate changes on cash (217) (1,407) 2,477
Increase/(Decrease) in cash and cash equivalents 11,404 13,852 1,773
Cash and cash equivalents beginning of period 54,268 40,416 38,643
Cash and cash equivalents end of period $ 65,672 $ 54,268 $ 40,416